Biostatistics HIV Working Group: Assessing Immunological Biomarker Surrogate Endpoints in COVID-19 Vaccine Efficacy Trials


Friday, November 6, 2020, 1:00pm to 1:50pm


Zoom Webinar

Peter Gilbert, Ph.D.

Professor, Vaccine and Infectious Disease/Public Health Sciences Divisions of the Fred Hutchinson Cancer Research Center, and Department of Biostatistics, University of Washington
Assessing Immunological Biomarker Surrogate Endpoints in COVID-19 Vaccine Efficacy Trials


Password: hiv_wg

Abstract: An objective of phase 3 preventive COVID-19 vaccine efficacy trials is to assess post-vaccination immunological biomarkers as various types of “immune correlates of protection,” with applications including to identify predictors/signatures of COVID-19 risk, modifiers of vaccine efficacy, and mediators of vaccine efficacy, and ultimately to define surrogate endpoints that can constitute the basis for traditional or accelerated approval, as well as for making bridging predictions of vaccine efficacy to new conditions different from those in the phase 3 trial. In this talk I will summarize the current statistical analysis plan of the COVID-19 Prevention Trials Network for assessing immune correlates of protection. Issues addressed include immunological biomarker sampling design, biomarker selection and optimization, methods for combining biomarkers to develop best predictors of study outcomes, principal stratification approaches to assessing vaccine efficacy moderation, causal mediation approaches to assessing the proportion of vaccine efficacy mediated through one or more biomarkers, a causal interventional approach that assesses how much mean outcome risk would be altered by stochastically shifting the biomarker distribution upwards, and meta-analysis of a set of phase 3 trials.  

More Zoom info:

Join by telephone (use any number to dial in)

    +1 301 715 8592

    +1 312 626 6799

    +1 929 436 2866

    +1 253 215 8782

    +1 346 248 7799

    +1 669 900 6833

International numbers available:

One tap mobile: +13017158592,,590782134# US (Germantown)


Join by SIP conference room system

Meeting ID: 590 782 134

Contact Jemar Bather or Lara Maleyeff with questions related to the working group, including requests to present.
Click here for more information on this series and a full list of dates and speakers.